Chadban, S. J. & Atkins, R. C. Glomerulonephritis. Lancet 365, 1797–1806 (2005).
Guo, Q., Wu, S., Xu, C., Wang, J. & Chen, J. Global disease burden from acute glomerulonephritis 1990–2019. Kidney Int. Rep. 6, 2212–2217 (2021).
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709–733 (2020).
Wetmore, J. B., Guo, H., Liu, J., Collins, A. J. & Gilbertson, D. T. The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis. Kidney Int. 90, 853–860 (2016).
United States Renal Data System. 2022 annual data report. https://usrds-adr.niddk.nih.gov/2022?dkrd=/about-niddk/strategic-plans-reports/usrds/annual-data-report (2022).
Titze, S. et al. Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort. Nephrol. Dial. Transplant. 30, 441–451 (2015).
Daehn, I. S. & Duffield, J. S. The glomerular filtration barrier: a structural target for novel kidney therapies. Nat. Rev. Drug Discov. 20, 770–788 (2021). This review explains the unique structure and function of the glomerular filtration barrier, and new ways by which its integrity might be preserved to treat glomerular disease.
Kopp, J. B. et al. Podocytopathies. Nat. Rev. Dis. Prim. 6, 68 (2020).
Grahammer, F. et al. A flexible, multilayered protein scaffold maintains the slit in between glomerular podocytes. JCI Insight 1, 86177 (2016).
Anguiano, L., Kain, R. & Anders, H. J. The glomerular crescent: triggers, evolution, resolution, and implications for therapy. Curr. Opin. Nephrol. Hypertens. 29, 302–309 (2020).
Kumar, S. V. et al. Neutrophil extracellular trap-related extracellular histones cause vascular necrosis in severe GN. J. Am. Soc. Nephrol. 26, 2399–2413 (2015). This study shows that severe immune glomerular injury is mediated by histones as products of NETs.
Kessenbrock, K. et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15, 623–625 (2009).
Cortinovis, M., Perico, N., Ruggenenti, P., Remuzzi, A. & Remuzzi, G. Glomerular hyperfiltration. Nat. Rev. Nephrol. 18, 435–451 (2022).
Kitching, A. R. & Hickey, M. J. Immune cell behaviour and dynamics in the kidney-insights from in vivo imaging. Nat. Rev. Nephrol. 18, 22–37 (2022). This review details the unusual immune milieu within the glomerulus and how leukocytes behave within glomerular capillaries to mediate GN.
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. Suppl. 100, S1–S276 (2021).
Sethi, S. et al. Mayo Clinic/Renal Pathology Society consensus report on pathologic classification, diagnosis, and reporting of GN. J. Am. Soc. Nephrol. 27, 1278–1287 (2016).
Lodi, L. et al. Type I interferon-related kidney disorders. Kidney Int. 101, 1142–1159 (2022).
Ravaglia, F. et al. The pathology lesion patterns of podocytopathies: how and why? Front. Cell Dev. Biol. 10, 838272 (2022).
Lerner, G. B., Virmani, S., Henderson, J. M., Francis, J. M. & Beck, L. H. Jr. A conceptual framework linking immunology, pathology, and clinical features in primary membranous nephropathy. Kidney Int. 100, 289–300 (2021).
Kumar, R. et al. Case report: unusual aggregation of different glomerulopathies in a family resolved by genetic testing and reverse phenotyping. Front. Pediatrics 10, 826330 (2022).
Smith, K. D. et al. Digital spatial profiling of collapsing glomerulopathy. Kidney Int. 101, 1017–1026 (2022).
Anders, H. J., Jayne, D. R. & Rovin, B. H. Hurdles to the introduction of new therapies for immune-mediated kidney diseases. Nat. Rev. Nephrol. 12, 205–216 (2016).
Carapetis, J. R., Steer, A. C., Mulholland, E. K. & Weber, M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5, 685–694 (2005).
Rodriguez-Iturbe, B. & Musser, J. M. The current state of poststreptococcal glomerulonephritis. J. Am. Soc. Nephrol. 19, 1855–1864 (2008).
Boils, C. L., Nasr, S. H., Walker, P. D., Couser, W. G. & Larsen, C. P. Update on endocarditis-associated glomerulonephritis. Kidney Int. 87, 1241–1249 (2015).
Satoskar, A. A., Parikh, S. V. & Nadasdy, T. Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nat. Rev. Nephrol. 16, 32–50 (2020).
Genovese, G. et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841–845 (2010).
Kopp, J. B. et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J. Am. Soc. Nephrol. 22, 2129–2137 (2011).
McGuire, B. M. et al. Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann. Intern. Med. 144, 735–741 (2006).
Kupin, W. L. Viral-associated GN: hepatitis B and other viral infections. Clin. J. Am. Soc. Nephrol. 12, 1529–1533 (2017).
Barsoum, R. S. Tropical parasitic nephropathies. Nephrol. Dial. Transplant. 14, 79–91 (1999).
Neves, P. et al. Schistosomiasis-associated glomerulopathy: clinical aspects, pathological characteristics, and renal outcomes. Clin. Nephrol. 93, 251–261 (2020).
Walker, A. et al. Eosinophilic glomerulonephritis in children in southwestern Uganda. Kidney Int. 71, 569–573 (2007).
Sethi, S., D’Costa, M. R., Hermann, S. M., Nasr, S. H. & Fervenza, F. C. Immune-complex glomerulonephritis after COVID-19 infection. Kidney Int. Rep. 6, 1170–1173 (2021).
Rodriguez-Iturbe, B. Autoimmunity in acute poststreptococcal GN: a neglected aspect of the disease. J. Am. Soc. Nephrol. 32, 534–542 (2021).
Yoshizawa, N. et al. Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response. J. Am. Soc. Nephrol. 15, 1785–1793 (2004).
Honda-Ogawa, M. et al. Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors. J. Biol. Chem. 288, 15854–15864 (2013).
Chauvet, S. et al. Anti-factor B antibodies and acute postinfectious GN in children. J. Am. Soc. Nephrol. 31, 829–840 (2020).
Nasr, S. H. et al. Postinfectious glomerulonephritis in the elderly. J. Am. Soc. Nephrol. 22, 187–195 (2011).
Couser, W. G. & Johnson, R. J. The etiology of glomerulonephritis: roles of infection and autoimmunity. Kidney Int. 86, 905–914 (2014).
Puelles, V. G. et al. Multiorgan and renal tropism of SARS-CoV-2. N. Engl. J. Med. 383, 590–592 (2020).
Li, J. et al. Transmembrane TNF-α facilitates HIV-1 infection of podocytes cultured from children with HIV-associated nephropathy. J. Am. Soc. Nephrol. 28, 862–875 (2017).
Araújo, S. A. et al. First report of collapsing variant of focal segmental glomerulosclerosis triggered by arbovirus: dengue and Zika virus infection. Clin. Kidney J. 12, 355–361 (2019).
Allam, R. et al. Viral RNA and DNA trigger common antiviral responses in mesangial cells. J. Am. Soc. Nephrol. 20, 1986–1996 (2009).
Gupta, S., Pepper, R. J., Ashman, N. & Walsh, S. B. Nephrotic syndrome: oedema formation and its treatment with diuretics. Front. Physiol. 9, 1868 (2018).
Fenaroli, P. et al. Collapsing glomerulopathy as a complication of type I interferon-mediated glomerulopathy in a patient with RNASEH2B-related Aicardi-Goutières syndrome. Am. J. Kidney Dis. 78, 750–754 (2021).
Migliorini, A. et al. The antiviral cytokines IFN-alpha and IFN-beta modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration. Am. J. Pathol. 183, 431–440 (2013).
Melica, M. E. et al. Differentiation of crescent-forming kidney progenitor cells into podocytes attenuates severe glomerulonephritis in mice. Sci. Transl. Med. 14, eabg3277 (2022). This study defines the participation of clonally expanded glomerular cells in severe glomerular injury and how tissue progenitors could assist in preserving glomerular structure and function in severe immune-mediated GN.
Nichols, B. et al. Innate immunity pathways regulate the nephropathy gene apolipoprotein L1. Kidney Int. 87, 332–342 (2015).
留言 (0)